As obesity pioneer Novo Nordisk…
As obesity pioneer Novo Nordisk loses ground in the race [...]
Mere months after its cancer…
Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga [...]
Amylyx’s withdrawn-from-market…
Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on [...]
Wugen has raised $115 million,…
Wugen has raised $115 million, tapping a Fidelity-led syndicate to [...]
Right on the heels of a similar…
Right on the heels of a similar deal, Fosun Pharma [...]
Eight months after Sanofi’s…
Eight months after Sanofi’s former Chief Medical Officer, Dietmar Berger, [...]
Regeneron has reported a phase 3…
Regeneron has reported a phase 3 win in generalized myasthenia [...]
Another cell therapy biotech has…
Another cell therapy biotech has run out of steam, this [...]
Akeso is adding a pair of…
Akeso is adding a pair of late-stage wins to its [...]
Amid a frozen-over IPO landscape,…
Amid a frozen-over IPO landscape, LB Pharmaceuticals has filed to [...]